Human Genome Sciences Inc Watch

from 10-K 21 pages Material contract

from 10-K 22 pages Material contract

from 10-K 21 pages Material contract

from 10-K 22 pages Material contract

from 10-Q 3 pages Second Amendment to the Human Genome Sciences, Inc. Second Amended and Restated Key Executive Severance Plan

from 10-Q 10 pages Form of Executive Agreement

from 10-Q 3 pages Third Amendment to the Employment Agreement by and Between Human Genome Sciences, Inc. and H. Thomas Watkins

from 10-K 10 pages Amendment No. 2 to the Co-Development and Commercialization Agreement

from 10-K 4 pages Amendment No. 1

from 10-Q 10 pages Form of Indemnification Agreement

from 10-K 14 pages Collateral Pledge Agreement Among Human Genome Sciences, Inc., as Pledgor, Manufacturers and Traders Trust Company, as Pledgee and Manufacturers and Traders Trust Company, Acting in Its Capacity as Collateral Agent Dated as of December 1, 2009 $23,000,000 Maryland Economic Development Corporation Taxable Variable Rate Demand/Fixed Rate Revenue Bonds (Human Genome Sciences, Inc. Facility) 1997 Issue and $17,500,000 Maryland Economic Development Corporation Taxable Variable Rate Demand/Fixed Rate Revenue Bonds (Human Genome Sciences, Inc. Facility) Series 1999 a and B Collateral Pledge Agreement

from 10-K 29 pages Human Genome Sciences, Inc., as Lessee and Manufacturers and Traders Trust Company, as Bank Reimbursement Agreement $17,500,000 Maryland Economic Development Corporation Taxable Variable Rate Demand/Fixed Rate Revenue Bonds (Human Genome Sciences, Inc. Facility) Series 1999 a and B Dated as of December 1, 2009

from 10-K 63 pages Amended and Restated Lease Agreement Between Maryland Economic Development Corporation and Human Genome Sciences, Inc. Dated December 1, 2009

from 10-K 28 pages Human Genome Sciences, Inc., as Lessee and Manufacturers and Traders Trust Company, as Bank Reimbursement Agreement $23,000,000 Maryland Economic Development Corporation Taxable Variable Rate Demand/Fixed Rate Revenue Bonds (Human Genome Sciences, Inc. Facility) 1997 Series Dated as of December 1, 2009

from 10-K 13 pages Amendment No. 1 to Lease Agreement

from 10-Q 10 pages (A) by Completing Items 8 and 15, and Returning Copies of the Amendment; (B) by Acknowledging Receipt of This Amendment on Each Copy of the Offer Submitted; or (C) by Separate Letter or Telegram Which Includes a Reference to the Solicitation and Amendment Numbers. Failure of Your Acknowledgement to Be Received at the Place Designated for the Receipt of Offers Prior to the Hour and Date Specified May Result in Rejection of Your Offer. if by Virtue of This Amendment, You Desire to Change an Offer Already Submitted, Such Change May Be Made by Telegram or Letter, Provided Each Telegram or Letter Makes Reference to the Solicitation and This Amendment, and Is Received Prior to the Opening Hour and Date Specified. 12. Accounting and Appropriation Data (If Required) Appropriation: 75-70-0513-0714-001; Fiscal Year: 2009; Can: 1993419; Object Class: 26201; Amount +$151,847,100.00

from 10-K 1 page Form of First Amendment to the Human Genome Sciences, Inc. Second Amended and Restated Key Executive Severance Plan

from 10-K 1 page Form of First Amendment to Executive Agreement

from 10-K 1 page Second Amendment to the Employment Agreement by and Between Human Genome Sciences, Inc. and H. Thomas Watkins

from 10-K 99 pages Co-Development and Commercialization Agreement Between Human Genome Sciences, Inc. and Glaxo Group Limited